// App-Quantinova.ai

P668 : Measured and modelled data suggest that oral administration of V565, a novel domain antibody to TNF-alpha, could be beneficial in the treatment of IBD

Researchers

Presenter

  • S Nurbhai

Principal Investigators

  • M West

  • T MacDonald

  • G Parkes

  • P Irving

  • A Vossenkaemper

  • S Crowe

Medical Centers

  • VHsquared Ltd., Cambridge, UK

  • QMUL, Blizard Institute, London, UK

  • Royal London Hospital, Barts Health NHS Trust, London, UK

  • Guys and St ThomasHospital, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved